Enovis reports Q1 2026 sales up 5% to $589 million; full-year guidance reaffirmed
Enovis reported first-quarter 2026 net sales of $589 million, up 5% on a reported basis and 3% organic, and a net loss of $8 million, or $0.15 per share, compared with a net loss of $55.7 million a year earlier. The company reaffirmed its full-year 2026 revenue, adjusted EBITDA, adjusted EPS and free cash flow conversion guidance, which matters to shareholders because it signals no change to its outlook.
Key points
- Net sales $589 million, up 5% reported and 3% organic; Reconstructive sales up 11% reported
- Net loss $8 million ($0.15 per share) versus a $55.7 million net loss in the prior-year quarter
- Adjusted EBITDA $104 million (17.6% of sales) and adjusted EPS $0.89, versus $0.65 a year earlier
- Full-year 2026 guidance reaffirmed: revenue $2.31-2.37 billion, adjusted EBITDA $425-435 million, adjusted EPS $3.52-3.73
The filing
Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.